Latest Selexis SA Stories
Selexis’ co-founder and scientific advisory board member will present, “Engineering the CHO Genome for Improved Transgene Integration and Expression” Geneva,
Company to Present Data on recently launched Selexis SURE CHO-Mplus™ Libraries Geneva, Switzerland (PRWEB) April 23, 2013 Geneva, Switzerland - April
Technology Addresses Secretion Bottlenecks in Recombinant Protein Expression. Geneva, Switzerland (PRWEB) April 17, 2013 Selexis SA, a serial innovation
Selexis to Meet with Companies Interested in Protein Drug Discovery, Cell Line Development and Lead Identification for Therapeutic Drug Development and Manufacturing. Geneva,
Selexis’ co-founder and scientific advisory board member, Nicolas Mermod, PhD, Professor of Biotechnology at Faculty of Biology and Medicine of the University of Lausanne, will present, “Engineering
- A morbid dread of being buried alive. Also spelled 'taphiphobia'.